Detection of ovarian cancer cells: Comparison of a telomerase assay and cytologic examination

Journal of the National Cancer Institute

Volumn 90, Issue 3, 1998, Pages 238-242

  Duggan, Bridgette D ^a   Wan, Minghong ^a   Yu, Mimi C ^b   Roman, Lynda D ^a   Muderspach, Laila I ^a   Delgadillo, Erika ^a   Li, Wei Zhi ^a   Martin, Sue Ellen ^a   Dubeau, Louis ^a,c  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^c Kenneth Norris Jr Compreh C   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TELOMERASE;

ARTICLE; ASCITES FLUID; CANCER CYTODIAGNOSIS; CLINICAL ARTICLE; ENZYME IMMUNOASSAY; FEMALE; HUMAN; OVARY CANCER; PERITONEAL FLUID;

EID: 0032481426     PISSN: 00278874     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnci/90.3.238     Document Type: Article

References (19)

1. Muderspach L, Muggia FM, Conti PS. Second-look laparotomy for stage III epithelial ovarian cancer: rationale and current issues. Cancer Treat Rev 1996;21:499-511.
2. Counter CM, Hirte HW, Bacchetti S, Harley CB. Telomerase activity in human ovarian carcinoma. Proc Natl Acad Sci U S A 1994;91: 2900-4.
3. Wan M, Li WZ, Duggan BD, Felix JC, Zhao Y, Dubeau L. Telomerase activity in benign and malignant epithelial ovarian tumors. J Natl Cancer Inst 1997;89:437-41.
4. Chong L, van Steensel B, Broccoli D, Erdjument-Bromage H, Hanish J, Tempst P, et al. A human telomeric protein. Science 1995;270: 1663-7.
5. Rhyu MS. Telomeres, telomerase, and immortality. J Natl Cancer Inst 1995;87:884-94.
6. Zakian VA. Telomeres: beginning to understand the end. Science 1995;270:1601-7.
7. Kim NW, Piatyszek MA, Prowse KR, Harley CB, West MD, Ho PL, et al. Specific association of human telomerase activity with immortal cells and cancer. Science 1994;266:2011-5.
8. Petersson F. Annual reports of results of treatment in gynecologic cancer. Nat J Gynecol Obstet 1991;21 (Suppl 36):238-9.
9. Buick RN, Pullano R, Trent JM. Comparative properties of five human ovarian adenocarcinoma cell lines. Cancer Res 1985;45:3668-76.
10. Dubeau L, Velicescu M, Sherrod AE, Schreiber G, Holt G. Culture of human fetal ovarian epithelium in a chemically-defined, serum-free medium: a model for ovarian carcinogenesis. Anticancer Res 1990;10:1233-40.
11. Dixon WJ, Massey FJ. Introduction to statistical analysis. New York: McGraw-Hill, 1969.
12. Bast RC Jr, Knauf S, Epenetos A, Dhokia B, Daly L, Tanner M, et al. Coordinate elevation of serum markers in ovarian cancer but not in benign disease. Cancer 1991;68:1758-63.
13. Boyle JO, Mao L, Brennen JA, Koch WM, Eisele DW, Saunders JR, et al. Gene mutations in saliva as molecular markers for head and neck squamous cell carcinomas. Am J Surg 1994;168:429-32.
14. Chen XQ, Stroun M, Magnenat JL, Nicod LP, Kurt AM, Lyautey J, et al. Microsatellite alterations in plasma DNA of small cell lung cancer patients. Nat Med 1996;2:1033-5.
15. Mao L, Lee DJ, Tockman MS, Erozan YS, Askin F, Sidransky D. Microsatellite alterations as clonal markers for the detection of human cancer. Proc Natl Acad Sci U S A 1994; 91:9871-5.
16. Nawroz H, Koch W, Anker P, Stroun M, Sidransky D. Microsatellite alterations in serum DNA of head and neck cancer patients. Nat Med 1996;2:1035-7.
17. Sidransky D, Von Eschenbach A, Tsai YC, Jones PA, Summerhayes I, Marshall F, et al. Identification of p53 gene mutations in bladder cancers and urine samples. Science 1994;266: 2011-4.
18. Ehlen T, Dubeau L. Detection of ras point mutations by polymerase chain reaction using mutation-specific, inosine-containing oligo-nucleotide primers. Biochem Biophys Res Commun 1989;160:441-7.
19. Califano J, Ahrendt SA, Meininger G, Westra WH, Koch WM, Sidransky D. Detection of telomerase activity in oral rinses from head and neck squamous cell carcinoma patients. Cancer Res 1996;56:5720-2.